Meeting Amwise – a Singapore biotech start up on cancer precision medicine and medical AI

Emily Event News Leave a Comment

In this write up, we feature Sean Huang, Founder of Amwise. This biotech start up is a leading brand in precision medicine to serve the well being of Asia cancer patients. The patented examination technology of Amwise is developed based on Asian genes and can identify the risk of tumor recurrence or metastasis, assisting doctors with second opinions. Amwise aims to …

Expanding from a pure API provider to new drug developer: Formosa is growing

Emily Event News Leave a Comment

Pictured Erick Co, CSO of Formosa Pharmaceutical during the acquisition of Activus Pharma, August 2017.  Formosa Pharma, Taiwan is a subsidiary of globally-recognized API provider, Formosa Laboratories. This preclinical and clinical stage biopharmaceutical company has a strong focus on anti-infective and oncology indications. Having recently acquired Activus Pharma and its Activus Pure Nanoparticle Technology Platform (APNT), Formosa Pharmaceuticals is growing …

Dr Chang (fourth from right) and his team at Immunwork

Five Questions with Immunwork

Emily Event News Leave a Comment

The biopharma industry in Asia is an exciting one. Despite uncertainty caused by a fragmented marketplace and different regulatory systems, innovators constantly overcome market challenges and produce useful inventions which brings the development of the industry to the next greater level. Among these is Immunwork, a Taiwanese biotech company which created an invention, T-E™ , a molecule containing both targeting (T) …